Home / Oligonucleotides and Peptides / Development and manufacturing / Analytical
TIDES Analytical
Services
Comprehensive peptide and oligonucleotide analytical services designed to simplify complexity, accelerate progress, and support confident decision-making from discovery through release.
Analytical insight that drives progress in peptide and oligonucleotide projects
We understand that analytical support isn’t just a checkpoint. It’s a critical enabler of progress across the TIDES development lifecycle. Our analytical platform is built to handle the unique complexities of all synthetic modalities with state-of-the-art instrumentation for structural characterization, impurity profiling, and stability studies. Whether you need method development, validation, or comprehensive release and stability testing, we tailor our approach to suit your molecule’s complexity and your program’s specific needs.
Working as an extension of your team, we help you navigate evolving regulatory expectations while maintaining the flexibility to adapt as your project advances. We combine deep expertise with a collaborative mindset, delivering timely, dependable data that helps accelerate decision-making and keep your development on track.
We eliminate friction and anticipate needs to streamline the path from analysis to action, reducing bottlenecks and minimizing delays. That means more than just meeting timelines; it means unlocking the confidence to move forward decisively.
From routine testing to solving the most intricate characterization challenges, we provide more than just data. We deliver analytical understanding that empowers you to make informed choices and reach each milestone with certainty. When complexity arises, we are ready to help turn it into your next breakthrough.

CLIENT TO PROVIDE STAT
CLIENT TO PROVIDE STAT
CLIENT TO PROVIDE STAT
Our technology
Our analytical platform is built to handle the unique complexity of peptides and oligonucleotides, with state-of-the-art instrumentation for structural characterization, impurity profiling, and stability studies.
We apply orthogonal methods and tailored strategies to ensure accurate, reliable results. From mass spectrometry to chromatography and peptide mapping, our technologies support fast, flexible decision-making. With a focus on continuous innovation, we equip your programs with the analytical depth needed to solve complexity and drive confident development forward.
Our quality
Quality is embedded into every aspect of our TIDES analytical services. From method development to release testing, we uphold rigorous global standards and ensure data integrity at every step.
Our teams bring deep expertise and a proactive mindset, combining scientific precision with a strong compliance framework. With robust processes and a focus on right-first-time execution, we help de-risk your development while ensuring your peptide and oligonucleotide programs progress with confidence and consistency across every milestone.
Our locations
Our global network of analytical sites spans North America, Europe, and Asia, offering comprehensive support across every development phase. Strategically co-located with TIDES API and drug product facilities, our labs ensure smooth handoffs and streamlined workflows. We combine global reach with local focus, bringing consistency and agility to your programs.
With the capacity, connectivity, and specialist expertise to manage even the most complex molecules, we help turn analytical challenges into measurable progress.
Our history
From its foundation, our journey has been defined by a commitment to innovation, quality, and strong partnerships, driven by a purpose-driven pace. We’ve rapidly evolved into a leading CRDMO with a perfectly orchestrated platform, consistently expanding our global footprint and capabilities to accelerate breakthroughs for our partners and patients worldwide.
Related content
Quantum Mechanics for Organic Chemists
Quantum Mechanics, Molecular Orbital Theory in particular, enables us to understand organic reactions at deeper levels.
Frequently Asked Questions
QM Magic Class | Chapter 38 Over the years, we received a lot of questions from our readers, below are...
WuXi STA Forms Strategic Partnership with Beta Pharma
STA will Accelerate Process R&D and Manufacturing of Late Phase and Commercial Targets STA Pharmaceutical Co., Ltd., (WuXi STA) –...